Will the lab-on-a-chip spell the end for laboratory analysers?
This article was originally published in Clinica
Doctors could be using lab-on-a-chip diagnostics in their offices within 18 months. Small automated point-of-care tests will be able to deliver faster, more convenient and less costly analyses, but the instruments are not the stuff of science fiction just yet, as Peter Rees reports.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.